MMITG A.I CyberSecurity Scoring
27/01/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Medtronic Minimally Invasive Therapies Group in 2026.
No incidents recorded for Medtronic Minimally Invasive Therapies Group in 2026.
No incidents recorded for Medtronic Minimally Invasive Therapies Group in 2026.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.
BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.
A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratory’s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time – and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from what’s now to what’s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person — regardless of who they are or where they are from — deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $12.7 billion in 2024, and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 31,000 employees worldwide in nearly 40 countries and regions.
Latest updates, reports, and threat intel affecting the global network.
Medtronic's Altaviva device advances urinary incontinence treatment with its minimally invasive tibial neuromodulation technology.
Medtronic's Altaviva device receives FDA approval for urge urinary incontinence treatment. Minimally invasive ankle implant offers 15-year...
My goal is to understand their respective AI journeys and share their views on the specific value the technology will bring to their organizations.
The randomized trial will use Tempus' platform to find patients who are eligible for interventions such as TAVR but do not have a treatment plan in place.
Medtronic has acquired Netherlands-based Fortimedix Surgical in a bid to boost its surgical and endoscopy portfolio.
Tornos is the new CEO of Zimmer Biomet, effective immediately, the company announced on Tuesday. Tornos has been COO of the company since 2021.
GE Healthcare is ranked among the largest internet of medical things (IoMT) industry players with its presence in the top-tier earning...
Mani Prakash, Vice President, Enterprise R&D, Medtronic, talks on the company's proposed R&D investments in India, changes in global...
India Medtronic Private Limited has presented a device that provides the enhanced precision to surgeons with convenience and safety in the...
PlaywrightCapture stored capture-specific configuration and runtime data as mutable class-level variables rather than instance-level variables. Consequently, multiple Capture objects running within the same Python process could share state, including HTTP headers, cookies, browser storage, HTTP credentials, proxy configuration, user-agent settings, geolocation information, and captured request data. In a multi-user or concurrent deployment, information supplied during one capture could therefore persist and be reused by a subsequent or parallel capture. This could result in the disclosure of authentication cookies, credentials, browser storage, or captured request data belonging to another user. It could also cause requests to be performed with another capture's authentication context, headers, or proxy configuration, potentially enabling unauthorized access to remote resources or interference with other capture operations. The vulnerability is resolved by initializing all capture-specific settings and request data as instance variables in the Capture constructor, ensuring that state is isolated between capture operations.
Anubis is a Web AI Firewall Utility that challenges users' connections in order to protect upstream resources from scraper bots. From 1.22.0 until 1.26.0-pre1, lib/policy/checker.go PathChecker.Check() trusted the client-controlled X-Original-URI header before matching r.URL.Path, allowing an HTTP client to match default data/common/keep-internet-working.yaml ALLOW rules such as ^/\.well-known/.*$ and bypass the Anubis challenge. This issue is fixed in version 1.26.0-pre1.
Wekan is open source kanban built with Meteor. Prior to 9.46, header-login with HEADER_LOGIN_TRUSTED_IPS uses getRequestIp() in server/lib/headerLoginAuth.js to trust the client-supplied X-Forwarded-For header before the real socket address, allowing an unauthenticated attacker to send HEADER_LOGIN_ID for any username and receive a meteor_login_token session, including for admin. This issue is fixed in version 9.46.
MaaAssistantArknights is a one-click tool for daily Arknights tasks. In the current dev-v2 workflow, .github/workflows/release-preparation.yml inlined attacker-controlled github.event.pull_request.title into a run: shell command during the pull_request opened, reopened, and ready_for_review events, so a non-draft fork PR whose title starts with Release v could execute shell commands on the ubuntu-latest runner during the generate-changelog job. This vulnerability is fixed by commit cafc3946059e6337d2089d4fec8b6885ba17c332.
Qinglong is a timed task management platform supporting Python3, JavaScript, Shell, and Typescript. Prior to 2.20.1, the init guard middleware in back/loaders/express.ts checks /api/user/init but not /open/user/init, while rewrite('/open/*', '/api/$1') rewrites the whitelisted /open/* path after JWT authentication and the guard have passed; an unauthenticated attacker can send PUT /open/user/init to reset administrator credentials on an initialized instance. This issue is fixed in 2.20.1.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.